Sign In
Buy LFMD
$4.56
-0.130 (-2.77%)
At Close: Jun 03, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LifeMD, Inc. - LFMD
01:55pm, Thursday, 21'st Aug 2025
NEW YORK, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of LifeMD, Inc. (“LifeMD” or the “Company”) (NASDAQ: LFMD). Such investors are a
LifeMD: The Dip Could Deepen, Valuation More Attractive
06:11am, Tuesday, 19'th Aug 2025
LifeMD saw year-over-year revenue growth for its second quarter slow markedly from the comparable figure in the first quarter. Gross profit margins dipped 200 basis points, versus its year-ago period,
LFMD Investors Have Opportunity to Join LifeMD, Inc. Fraud Investigation with the Schall Law Firm
06:16pm, Saturday, 16'th Aug 2025
LOS ANGELES--(BUSINESS WIRE)---- $LFMD--LFMD Investors Have Opportunity to Join LifeMD, Inc. Fraud Investigation with the Schall Law Firm.
NEW YORK, Aug. 16, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of LifeMD, Inc.
LifeMD, Inc. Investors: Company Investigated by the Portnoy Law Firm
03:57pm, Thursday, 14'th Aug 2025
Investors can contact the law firm at no cost to learn more about recovering their losses
LFMD Investor News: Rosen Law Firm Encourages LifeMD, Inc. Investors to Inquire About Securities Class Action Investigation - LFMD
02:40pm, Thursday, 14'th Aug 2025
NEW YORK , Aug. 14, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of LifeMD, Inc. (N
Rosen Law Firm Encourages LifeMD, Inc. Investors to Inquire About Securities Class Action Investigation – LFMD
11:21am, Wednesday, 13'th Aug 2025
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of LifeMD, Inc. (NASDAQ: LFMD) re
LifeMD (LFMD) Q2 Revenue Rises 23%
12:38am, Wednesday, 06'th Aug 2025
LifeMD (LFMD) Q2 Revenue Rises 23%
LifeMD, Inc. (LFMD) Q2 2025 Earnings Call Transcript
07:51pm, Tuesday, 05'th Aug 2025
LifeMD, Inc. (NASDAQ:LFMD ) Q2 2025 Earnings Conference Call August 5, 2025 4:30 PM ET Company Participants Justin Schreiber - Chairman & CEO Marc Benathen - Chief Financial Officer Conference Call Pa
LifeMD, Inc. (LFMD) Reports Q2 Loss, Lags Revenue Estimates
07:06pm, Tuesday, 05'th Aug 2025
LifeMD, Inc. (LFMD) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to a loss of $0.19 per share a year ago.
LifeMD Reports Second Quarter 2025 Results
04:05pm, Tuesday, 05'th Aug 2025
Total revenue increased 23% year-over-year to $62.2 million; adjusted EBITDA rose 223% to $7.1 million Telehealth revenue increased 30% to $48.6 million; telehealth adjusted EBITDA rose 560% to $3.4 m
Medifast Announces Second Quarter 2025 Financial Results
04:05pm, Monday, 04'th Aug 2025
BALTIMORE--(BUSINESS WIRE)--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the second quarte
LifeMD to Participate in the Canaccord Genuity 45th Annual Growth Conference
08:00am, Monday, 04'th Aug 2025
NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced its participation in the Canaccord Genuity 45th Annual Gro
LifeMD Names COO and Promotes Two Executives
08:00am, Thursday, 31'st Jul 2025
NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual healthcare services, today announced the appointment of Shayna Webb Dray as its Chief Operating O
Hims & Hers vs. LifeMD: Which Telehealth Stock Has More Upside?
11:15am, Monday, 30'th Jun 2025
HIMS and LFMD are surging in the telehealth race, but which one has stronger earnings growth and expansion momentum? Let's see.
